UBS Group »

Entero Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Entero Therapeutics shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Entero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entero Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entero Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $330 66 5.00